Barrett's Esophagus

Clinicians should factor comorbidity status and sex when considering the optimal age to discontinue surveillance in patients with non-dysplastic Barrett’s esophagus.

The prevalence of Barrett’s esophagus was 12.8% among women with scleroderma, according to a study published in the American Journal of Gastroenterology.

Healio Gastroenterology presents the following reports on the most recent research on the esophagus and GERD.

Researchers were able obtain high-quality images of Barrett’s esophagus using tethered capsule endomicroscopy, according to study results.

The top stories in gastroenterology last week were based on data presented during the American College of Gastroenterology Annual Scientific Meeting.

Cryoballoon ablation was safe and effective in patients with neoplastic Barrett’s esophagus, according to a study published in the American Journal of Gastroenterology.

Barrett’s esophagus intervention effectively improved overall disease-specific survival, according to a presentation at the American College of Gastroenterology Virtual Annual Scientific Meeting.

A novel esophageal capsule was not seen as ready for population screening for Barrett’s Esophagus, according to results form a pilot study.

Famotidine use was associated with a lower risk for adverse outcomes among patients hospitalized with COVID-19, according to a recent study. It was the top story in gastroenterology last week.

Patients who underwent esophagogastroduodenoscopy after sleeve gastrectomy experienced a high prevalence of Barrett’s esophagus, according to results published in Gastrointestinal Endoscopy.